Skip to main content
eScholarship
Open Access Publications from the University of California
Refine Search

UC San Diego

UC San Diego Previously Published Works bannerUC San Diego

Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia.

Published Web Location

https://doi.org/10.1158/2767-9764.CRC-24-0258
Abstract

This article reports preclinical development of TUS, an oral kinase inhibitor currently in clinical development for treatment of AML. The article covers the studies of TUS activities on cellular targets and the nonclinical studies that supported the advancement of TUS to a phase I/II trial of TUS/VEN in refractory AML and a phase I/II trial of TUS/VEN/5-azacytidine in newly diagnosed patients with AML (NCT03850574).

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View


Top